Shopping Cart
- Remove All
- Your shopping cart is currently empty
Naproxcinod, a nitric oxide-releasing NSAID derivative, significantly improved skeletal muscle strength and fatigue resistance in sedentary and exercise mice, reducing inflammatory infiltration and fibrotic deposition in the myocardium and diaphragm. In addition to its anti-inflammatory activity, Naproxcinod is a promising candidate for the treatment of Duchenne muscular dystrophy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | 6-8 weeks | |
50 mg | 1.881 € | 6-8 weeks | |
100 mg | 2.375 € | 6-8 weeks |
Description | Naproxcinod, a nitric oxide-releasing NSAID derivative, significantly improved skeletal muscle strength and fatigue resistance in sedentary and exercise mice, reducing inflammatory infiltration and fibrotic deposition in the myocardium and diaphragm. In a |
Alias | Nitronaproxen, Naproxen-N-butyl nitrate, HCT3012, AZD-3582, AZD3582, AZD 3582 |
Molecular Weight | 347.36 |
Formula | C18H21NO6 |
Cas No. | 163133-43-5 |
Relative Density. | 1.213 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.